文献速递肺结节与肺癌

机器学习利用常规临床与实验室数据早期识别肺癌

Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

研究基于6505例非小细胞肺癌患者和189597例对照,开发机器学习模型预测未来肺癌诊断,并与mPLCOm2012模型比较。在吸烟者测试集中,机器学习模型在临床诊断前9-12个月识别NSCLC的AUC为0.86,优于mPLCOm2012的0.79,且灵敏度更高。该模型可能通过早期检测帮助预防肺癌死亡。

要点

  • 机器学习模型在吸烟者中预测9-12个月后NSCLC的AUC达0.86,优于mPLCOm2012的0.79。
  • 在预设特异度95%时,机器学习模型灵敏度40.1%,高于mPLCOm2012的27.9%。
  • 模型优于标准筛查入选标准,且纳入白细胞和血小板计数等新预测因子。

核心结论

  • 机器学习模型对NSCLC早期诊断的准确性优于标准筛查入选标准和mPLCOm2012模型,展示通过早期检测预防肺癌死亡的潜力。

研究设计与样本

  • 研究纳入6505例非小细胞肺癌患者和189597例同期对照,比较机器学习模型与mPLCOm2012模型的预测性能。

主要发现

  • 在吸烟者测试集中,机器学习模型识别临床诊断前9-12个月NSCLC的AUC为0.86,诊断OR为12.3,预设特异度95%时灵敏度为40.1%。
  • mPLCOm2012模型在同一特异度下AUC为0.79,OR为7.4,灵敏度为27.9%。
  • 机器学习模型在筛查合格人群中比标准筛查入选标准和mPLCOm2012更准确。
  • 有影响力的模型变量包括已知风险因素以及白细胞和血小板计数等新预测因子。

临床怎么用

  • 该模型基于常规临床和实验室数据,可辅助识别肺癌高危个体,促进早期干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Most lung cancers are diagnosed at an advanced stage. Presymptomatic identification of high-risk individuals can prompt earlier intervention and improve long-term outcomes. Objectives: To develop a model to predict a future diagnosis of lung cancer on the basis of routine clinical and laboratory data by using machine learning. Methods: We assembled data from 6,505 case patients with non-small cell lung cancer (NSCLC) and 189,597 contemporaneous control subjects and compared the accuracy of a novel machine learning model with a modified version of the well-validated 2012 Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial risk model (mPLCOm2012), by using the area under the receiver operating characteristic curve (AUC), sensitivity, and diagnostic odds ratio (OR) as measures of model performance. Measurements and Main Results: Among ever-smokers in the test set, a machine learning model was more accurate than the mPLCOm2012 for identifying NSCLC 9-12 months before clinical diagnosis (P < 0.00001) and demonstrated an AUC of 0.86, a diagnostic OR of 12.3, and a sensitivity of 40.1% at a predefined specificity of 95%. In comparison, the mPLCOm2012 demonstrated an AUC of 0.79, an OR of 7.4, and a sensitivity of 27.9% at the same specificity. The machine learning model was more accurate than standard eligibility criteria for lung cancer screening and more accurate than the mPLCOm2012 when applied to a screening-eligible population. Influential model variables included known risk factors and novel predictors such as white blood cell and platelet counts. Conclusions: A machine learning model was more accurate for early diagnosis of NSCLC than either standard eligibility criteria for screening or the mPLCOm2012, demonstrating the potential to help prevent lung cancer deaths through early detection.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Gould MK, Huang BZ, Tammemagi MC, et al. Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data. Am J Respir Crit Care Med. 2021. PMID: 33823116. doi:10.1164/rccm.202007-2791OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。